MoneyWorks4Me

Morepen Laboratories’ arm to incorporate wholly owned subsidiary

25 Jul 2025 Evaluate

Morepen Laboratories’ subsidiary -- Morepen Medipath (MML) has received approval from its board to incorporate a new wholly owned subsidiary named SIGMACHECK HEALTH. Upon incorporation, the aforesaid named company will become a step-down subsidiary of the company. The objective behind the incorporation is to cater the growing demands of the medical devices.  The company will indirectly hold 60% of the equity shares in the proposed new step-down subsidiary through MML.

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.

Morepen Laboratories Share Price

113.70 -3.70 (-3.15%)
04-Sep-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: